Ranibizumab for treating diabetic macular oedema

Technology appraisal guidance
Reference number: TA274
Published: 27 February 2013
Last updated: 26 October 2023

Information for the public

Ranibizumab for diabetic macular oedema (PDF 111 KB)

Published:

27 February 2013
Gwybodaeth i'r cyhoedd (Word 337 KB)

Published:

07 October 2013